Comparison of Full-Dose vs Moderate-Dose Systemic Thrombolysis for the Treatment of Patients With Acute Pulmonary Embolism

Chest. 2022 Aug;162(2):448-451. doi: 10.1016/j.chest.2022.02.026. Epub 2022 Feb 20.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Pulmonary Embolism* / etiology
  • Thrombolytic Therapy
  • Treatment Outcome

Substances

  • Fibrinolytic Agents